{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:06:49Z","timestamp":1784099209764,"version":"3.55.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-026-02259-y","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:47:54Z","timestamp":1776703674000},"page":"4529-4545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Brain, benefit, or burden? Revisiting statins and cognitive function in older adults"],"prefix":"10.1007","volume":"48","author":[{"given":"Yiwen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2625-0273","authenticated-orcid":false,"given":"Setor K.","family":"Kunutsor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"2259_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/14779072.2017.1357468","volume":"15","author":"SK Kunutsor","year":"2017","unstructured":"Kunutsor SK, Whitehouse MR, Blom AW, Laukkanen JA. Statins and venous thromboembolism: do they represent a viable therapeutic agent? Expert Rev Cardiovasc Ther. 2017;15:629\u201337.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2259_CR2","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","volume":"63","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2889\u2013934.","journal-title":"J Am Coll Cardiol"},{"key":"2259_CR3","doi-asserted-by":"crossref","unstructured":"Cholesterol Treatment Trialists C. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet. 2019;393:407\u201315.","DOI":"10.1016\/S0140-6736(18)31942-1"},{"key":"2259_CR4","unstructured":"FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-important-safety-label-changes-cholesterol-lowering-statin-drugs?. Accessed 8 Jan 2026."},{"key":"2259_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","volume":"19","author":"M Schachter","year":"2005","unstructured":"Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol. 2005;19:117\u201325.","journal-title":"Fundam Clin Pharmacol"},{"key":"2259_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1159\/000506151","volume":"145","author":"SK Kunutsor","year":"2020","unstructured":"Kunutsor SK, Laukkanen JA. Heart failure risk reduction: hydrophilic or lipophilic statins? Cardiology. 2020;145:384\u20136.","journal-title":"Cardiology"},{"key":"2259_CR7","unstructured":"Collaborators GBDDF. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105\u2013e25."},{"key":"2259_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1210\/er.2011-1049","volume":"33","author":"J Kang","year":"2012","unstructured":"Kang J, Rivest S. Lipid metabolism and neuroinflammation in Alzheimer\u2019s disease: a role for liver X receptors. Endocr Rev. 2012;33:715\u201346.","journal-title":"Endocr Rev"},{"key":"2259_CR9","doi-asserted-by":"crossref","unstructured":"Westphal Filho FL, Moss Lopes PR, Menegaz de Almeida A, Sano VKT, Tamashiro FM, Goncalves OR, et al. Statin use and dementia risk: a systematic review and updated meta-analysis. Alzheimers Dement (N Y). 2025;11:e70039.","DOI":"10.1002\/trc2.70039"},{"key":"2259_CR10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004818","volume":"90","author":"L Sinyavskaya","year":"2018","unstructured":"Sinyavskaya L, Gauthier S, Renoux C, Dell\u2019Aniello S, Suissa S, Brassard P. Comparative effect of statins on the risk of incident Alzheimer disease. Neurology. 2018;90:e179-e87.","journal-title":"Neurology"},{"key":"2259_CR11","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative G. MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7\u201322.","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"2259_CR12","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","volume":"360","author":"J Shepherd","year":"2002","unstructured":"Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623\u201330.","journal-title":"Lancet"},{"key":"2259_CR13","doi-asserted-by":"publisher","first-page":"24F","DOI":"10.1016\/j.amjcard.2005.06.009","volume":"96","author":"JK Liao","year":"2005","unstructured":"Liao JK. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol. 2005;96:24F-33F.","journal-title":"Am J Cardiol"},{"key":"2259_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/01.ATV.0000151647.14923.ec","volume":"25","author":"A Undas","year":"2005","unstructured":"Undas A, Brummel-Ziedins KE, Mann KG. Statins and blood coagulation. Arterioscler Thromb Vasc Biol. 2005;25:287\u201394.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2259_CR15","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/eurheartj\/ehx107","volume":"38","author":"SK Kunutsor","year":"2017","unstructured":"Kunutsor SK, Seidu S, Khunti K. Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies. Eur Heart J. 2017;38:1608\u201312.","journal-title":"Eur Heart J"},{"key":"2259_CR16","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/S2352-3026(16)30184-3","volume":"4","author":"SK Kunutsor","year":"2017","unstructured":"Kunutsor SK, Seidu S, Khunti K. Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis. Lancet Haematol. 2017;4:e83\u201393.","journal-title":"Lancet Haematol"},{"key":"2259_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-018-0110-3","volume":"7","author":"BG Schultz","year":"2018","unstructured":"Schultz BG, Patten DK, Berlau DJ. The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms. Transl Neurodegener. 2018;7:5.","journal-title":"Transl Neurodegener"},{"key":"2259_CR18","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.3233\/JAD-220317","volume":"90","author":"R Waziry","year":"2022","unstructured":"Waziry R, Claus JJ, Hofman A. Dementia risk following ischemic stroke: a systematic review and meta-analysis of factors collected at time of stroke diagnosis. J Alzheimers Dis. 2022;90:1535\u201346.","journal-title":"J Alzheimers Dis"},{"key":"2259_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMoa061894","volume":"355","author":"P Amarenco","year":"2006","unstructured":"Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549\u201359.","journal-title":"N Engl J Med"},{"key":"2259_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1001\/jamaneurol.2021.5578","volume":"79","author":"M Lee","year":"2022","unstructured":"Lee M, Cheng CY, Wu YL, Lee JD, Hsu CY, Ovbiagele B. Association between intensity of low-density lipoprotein cholesterol reduction with statin-based therapies and secondary stroke prevention: a meta-analysis of randomized clinical trials. JAMA Neurol. 2022;79:349\u201358.","journal-title":"JAMA Neurol"},{"key":"2259_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/WCO.0000000000000913","volume":"34","author":"MC Zanon Zotin","year":"2021","unstructured":"Zanon Zotin MC, Sveikata L, Viswanathan A, Yilmaz P. Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management. Curr Opin Neurol. 2021;34:246\u201357.","journal-title":"Curr Opin Neurol"},{"key":"2259_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23115938","author":"DM Teleanu","year":"2022","unstructured":"Teleanu DM, Niculescu AG, Lungu II, Radu CI, Vladacenco O, Roza E, et al. An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23115938.","journal-title":"Int J Mol Sci"},{"key":"2259_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0323749","volume":"20","author":"S Sabeel","year":"2025","unstructured":"Sabeel S, Motaung B, Nguyen KA, Ozturk M, Mukasa SL, Wolmarans K, et al. Impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases: a systematic review and meta-analysis. PLoS ONE. 2025;20:e0323749.","journal-title":"PLoS ONE"},{"key":"2259_CR24","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00134-009-1429-0","volume":"35","author":"V Novack","year":"2009","unstructured":"Novack V, Eisinger M, Frenkel A, Terblanche M, Adhikari NK, Douvdevani A, et al. The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial. Intensive Care Med. 2009;35:1255\u201360.","journal-title":"Intensive Care Med"},{"key":"2259_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","volume":"60","author":"K Koushki","year":"2021","unstructured":"Koushki K, Shahbaz SK, Mashayekhi K, Sadeghi M, Zayeri ZD, Taba MY, et al. Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways. Clin Rev Allergy Immunol. 2021;60:175\u201399.","journal-title":"Clin Rev Allergy Immunol"},{"key":"2259_CR26","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1089\/ars.2013.5430","volume":"20","author":"M Margaritis","year":"2014","unstructured":"Margaritis M, Channon KM, Antoniades C. Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering. Antioxid Redox Signal. 2014;20:1198\u2013215.","journal-title":"Antioxid Redox Signal"},{"key":"2259_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/heartasia-2011-010045","volume":"3","author":"S Bleda","year":"2011","unstructured":"Bleda S, De Haro J, Florez A, Varela C, Esparza L, Acin F. Long-term pleiotropic effect of statins upon nitric oxide and C-reactive protein levels in patients with peripheral arterial disease. Heart Asia. 2011;3:130\u20134.","journal-title":"Heart Asia"},{"key":"2259_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032909","author":"YC Fang","year":"2023","unstructured":"Fang YC, Hsieh YC, Hu CJ, Tu YK. Endothelial dysfunction in neurodegenerative diseases. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032909.","journal-title":"Int J Mol Sci"},{"key":"2259_CR29","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73:924\u201367.","journal-title":"Pharmacol Rev"},{"key":"2259_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.tcm.2006.03.003","volume":"16","author":"JA Beckman","year":"2006","unstructured":"Beckman JA, Creager MA. The nonlipid effects of statins on endothelial function. Trends Cardiovasc Med. 2006;16:156\u201362.","journal-title":"Trends Cardiovasc Med"},{"key":"2259_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122051","author":"AM Gorabi","year":"2019","unstructured":"Gorabi AM, Kiaie N, Hajighasemi S, Banach M, Penson PE, Jamialahmadi T, et al. Statin-induced nitric oxide signaling: mechanisms and therapeutic implications. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8122051.","journal-title":"J Clin Med"},{"key":"2259_CR32","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1038\/jcbfm.2012.122","volume":"32","author":"S Giannopoulos","year":"2012","unstructured":"Giannopoulos S, Katsanos AH, Tsivgoulis G, Marshall RS. Statins and cerebral hemodynamics. J Cereb Blood Flow Metab. 2012;32:1973\u20136.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2259_CR33","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1161\/hs1201.099663","volume":"32","author":"P Sterzer","year":"2001","unstructured":"Sterzer P, Meintzschel F, Rosler A, Lanfermann H, Steinmetz H, Sitzer M. Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease. Stroke. 2001;32:2817\u201320.","journal-title":"Stroke"},{"key":"2259_CR34","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s00421-022-05022-1","volume":"122","author":"SE Aaron","year":"2022","unstructured":"Aaron SE, Tomoto T, Zhang R, Thyfault JP, Vidoni ED, Montgomery RN, et al. Statin contribution to middle cerebral artery blood flow velocity in older adults at risk for dementia. Eur J Appl Physiol. 2022;122:2417\u201326.","journal-title":"Eur J Appl Physiol"},{"key":"2259_CR35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang J, Liu Q. Cholesterol metabolism and homeostasis in the brain. Protein Cell. 2015;6:254\u201364.","journal-title":"Protein Cell"},{"key":"2259_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/biom14030362","author":"B Viljetic","year":"2024","unstructured":"Viljetic B, Blazetic S, Labak I, Ivic V, Zjalic M, Heffer M, et al. Lipid rafts: the maestros of normal brain development. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14030362.","journal-title":"Biomolecules"},{"key":"2259_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/292598","volume":"2012","author":"M Orth","year":"2012","unstructured":"Orth M, Bellosta S. Cholesterol: its regulation and role in central nervous system disorders. Cholesterol. 2012;2012:292598.","journal-title":"Cholesterol"},{"key":"2259_CR38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.mcn.2005.02.006","volume":"29","author":"C Goritz","year":"2005","unstructured":"Goritz C, Mauch DH, Pfrieger FW. Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron. Mol Cell Neurosci. 2005;29:190\u2013201.","journal-title":"Mol Cell Neurosci"},{"key":"2259_CR39","doi-asserted-by":"publisher","first-page":"16067","DOI":"10.3390\/ijms160716067","volume":"16","author":"PM Tricarico","year":"2015","unstructured":"Tricarico PM, Crovella S, Celsi F. Mevalonate pathway blockade, mitochondrial dysfunction and autophagy: a possible link. Int J Mol Sci. 2015;16:16067\u201384.","journal-title":"Int J Mol Sci"},{"key":"2259_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jcsm.12654","volume":"12","author":"H Mollazadeh","year":"2021","unstructured":"Mollazadeh H, Tavana E, Fanni G, Bo S, Banach M, Pirro M, et al. Effects of statins on mitochondrial pathways. J Cachexia Sarcopenia Muscle. 2021;12:237\u201351.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2259_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40268-024-00474-6","volume":"24","author":"K Chen","year":"2024","unstructured":"Chen K, Chen Y, Huang H. Exploring the relationship between atorvastatin and memory loss: a comprehensive analysis integrating real-world pharmacovigilance and mendelian randomization. Drugs R D. 2024;24:317\u201329.","journal-title":"Drugs R D"},{"key":"2259_CR42","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.12659\/MSM.890777","volume":"20","author":"A Skarlovnik","year":"2014","unstructured":"Skarlovnik A, Janic M, Lunder M, Turk M, Sabovic M. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Med Sci Monit. 2014;20:2183\u20138.","journal-title":"Med Sci Monit"},{"key":"2259_CR43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1532-5415.1997.tb00971.x","volume":"45","author":"NC Santanello","year":"1997","unstructured":"Santanello NC, Barber BL, Applegate WB, Elam J, Curtis C, Hunninghake DB, et al. Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study. J Am Geriatr Soc. 1997;45:8\u201314.","journal-title":"J Am Geriatr Soc"},{"key":"2259_CR44","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41440-018-0165-7","volume":"42","author":"H Zhang","year":"2019","unstructured":"Zhang H, Cui Y, Zhao Y, Dong Y, Duan D, Wang J, et al. Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial. Hypertens Res. 2019;42:717\u201329.","journal-title":"Hypertens Res"},{"key":"2259_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jacl.2020.10.007","volume":"15","author":"A Adhikari","year":"2021","unstructured":"Adhikari A, Tripathy S, Chuzi S, Peterson J, Stone NJ. Association between statin use and cognitive function: a systematic review of randomized clinical trials and observational studies. J Clin Lipidol. 2021;15:22-32 e12.","journal-title":"J Clin Lipidol"},{"key":"2259_CR46","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/jgs.18312","volume":"71","author":"J Joseph","year":"2023","unstructured":"Joseph J, Pajewski NM, Dolor RJ, Sellers MA, Perdue LH, Peeples SR, et al. Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): trial design and rationale. J Am Geriatr Soc. 2023;71:1701\u201313.","journal-title":"J Am Geriatr Soc"},{"key":"2259_CR47","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archneur.59.3.378","volume":"59","author":"K Yaffe","year":"2002","unstructured":"Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol. 2002;59:378\u201384.","journal-title":"Arch Neurol"},{"key":"2259_CR48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/archneur.59.2.223","volume":"59","author":"K Rockwood","year":"2002","unstructured":"Rockwood K, Kirkland S, Hogan DB, MacKnight C, Merry H, Verreault R, et al. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol. 2002;59:223\u20137.","journal-title":"Arch Neurol"},{"key":"2259_CR49","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1212\/01.wnl.0000182897.18229.ec","volume":"65","author":"C Bernick","year":"2005","unstructured":"Bernick C, Katz R, Smith NL, Rapp S, Bhadelia R, Carlson M, et al. Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology. 2005;65:1388\u201394.","journal-title":"Neurology"},{"key":"2259_CR50","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1532-5415.2007.01071.x","volume":"55","author":"JV Agostini","year":"2007","unstructured":"Agostini JV, Tinetti ME, Han L, McAvay G, Foody JM, Concato J. Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults. J Am Geriatr Soc. 2007;55:420\u20135.","journal-title":"J Am Geriatr Soc"},{"key":"2259_CR51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/JAD-2010-100180","volume":"21","author":"J Benito-Leon","year":"2010","unstructured":"Benito-Leon J, Louis ED, Vega S, Bermejo-Pareja F. Statins and cognitive functioning in the elderly: a population-based study. J Alzheimers Dis. 2010;21:95\u2013102.","journal-title":"J Alzheimers Dis"},{"key":"2259_CR52","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1016\/j.jacc.2019.09.041","volume":"74","author":"K Samaras","year":"2019","unstructured":"Samaras K, Makkar SR, Crawford JD, Kochan NA, Slavin MJ, Wen W, et al. Effects of statins on memory, cognition, and brain volume in the elderly. J Am Coll Cardiol. 2019;74:2554\u201368.","journal-title":"J Am Coll Cardiol"},{"key":"2259_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63035-2","volume":"10","author":"AM Alsehli","year":"2020","unstructured":"Alsehli AM, Olivo G, Clemensson LE, Williams MJ, Schioth HB. The cognitive effects of statins are modified by age. Sci Rep. 2020;10:6187.","journal-title":"Sci Rep"},{"key":"2259_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8020030","author":"MY Kim","year":"2020","unstructured":"Kim MY, Jung M, Noh Y, Shin S, Hong CH, Lee S, et al. Impact of statin use on dementia incidence in elderly men and women with ischemic heart disease. Biomedicines. 2020. https:\/\/doi.org\/10.3390\/biomedicines8020030.","journal-title":"Biomedicines"},{"key":"2259_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285529","volume":"18","author":"C Murphy","year":"2023","unstructured":"Murphy C, Dyer AH, Lawlor B, Kennelly SP, group Ns. What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease? PLoS ONE. 2023;18:e0285529.","journal-title":"PLoS ONE"},{"key":"2259_CR56","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209168","volume":"102","author":"KB Rajan","year":"2024","unstructured":"Rajan KB, McAninch EA, Wilson RS, Dhana A, Evans-Lacko S, Evans DA. Statin initiation and risk of incident Alzheimer disease and cognitive decline in genetically susceptible older adults. Neurology. 2024;102:e209168.","journal-title":"Neurology"},{"key":"2259_CR57","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jamda.2023.11.010","volume":"25","author":"M Sun","year":"2024","unstructured":"Sun M, Chen WM, Wu SY, Zhang J. Protective effects against dementia undergo different statin type, intensity, and cumulative dose in older adult type 2 diabetes mellitus patients. J Am Med Dir Assoc. 2024;25:470-9 e1.","journal-title":"J Am Med Dir Assoc"},{"key":"2259_CR58","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.amjmed.2024.03.016","volume":"137","author":"G Gjyriqi","year":"2024","unstructured":"Gjyriqi G, Gross A, Burns E, Gianos E, Sidhu MS, Mathew RO. Patterns of statin therapy use and associated outcomes in older veterans across kidney function. Am J Med. 2024;137:839-46 e1.","journal-title":"Am J Med"},{"key":"2259_CR59","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/eurjpc\/zwab208","volume":"29","author":"E Olmastroni","year":"2022","unstructured":"Olmastroni E, Molari G, De Beni N, Colpani O, Galimberti F, Gazzotti M, et al. Statin use and risk of dementia or Alzheimer\u2019s disease: a systematic review and meta-analysis of observational studies. Eur J Prev Cardiol. 2022;29:804\u201314.","journal-title":"Eur J Prev Cardiol"},{"key":"2259_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1473796","volume":"16","author":"Y Du","year":"2025","unstructured":"Du Y, Yu Z, Li C, Zhang Y, Xu B. The role of statins in dementia or Alzheimer\u2019s disease incidence: a systematic review and meta-analysis of cohort studies. Front Pharmacol. 2025;16:1473796.","journal-title":"Front Pharmacol"},{"key":"2259_CR61","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jacc.2022.05.041","volume":"80","author":"DB Rosoff","year":"2022","unstructured":"Rosoff DB, Bell AS, Jung J, Wagner J, Mavromatis LA, Lohoff FW. Mendelian randomization study of PCSK9 and HMG-CoA reductase inhibition and cognitive function. J Am Coll Cardiol. 2022;80:653\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"2259_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.120057","volume":"391","author":"J Fu","year":"2025","unstructured":"Fu J, Zhang Z, Xu Y, Han L, Fan H, Lu Y. Mendelian randomization analysis of lipids traits and lipid-lowering drug-targets in relation to cognitive status. J Affect Disord. 2025;391:120057.","journal-title":"J Affect Disord"},{"key":"2259_CR63","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1648","volume":"357","author":"M Benn","year":"2017","unstructured":"Benn M, Nordestgaard BG, Frikke-Schmidt R, Tybjaerg-Hansen A. Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer\u2019s disease and Parkinson\u2019s disease: mendelian randomisation study. BMJ. 2017;357:j1648.","journal-title":"BMJ"},{"key":"2259_CR64","doi-asserted-by":"crossref","unstructured":"Rojas-Fernandez CH, Goldstein LB, Levey AI, Taylor BA, Bittner V, The National Lipid Association\u2019s Safety Task F. An assessment by the Statin Cognitive Safety Task Force: 2014 update. J Clin Lipidol. 2014;8:S5\u201316.","DOI":"10.1016\/j.jacl.2014.02.013"},{"key":"2259_CR65","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jacl.2014.03.003","volume":"8","author":"TA Jacobson","year":"2014","unstructured":"Jacobson TA. NLA task force on statin safety--2014 update. J Clin Lipidol. 2014;8:S1-4.","journal-title":"J Clin Lipidol"},{"key":"2259_CR66","doi-asserted-by":"crossref","unstructured":"Force USPST, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Jr., et al. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement. JAMA. 2016;316:1997\u20132007.","DOI":"10.1001\/jama.2016.15450"},{"key":"2259_CR67","first-page":"110","volume":"15","author":"PV Rabins","year":"2017","unstructured":"Rabins PV, Rovner BW, Rummans T, Schneider LS, Tariot PN. Guideline watch (October 2014): practice guideline for the treatment of patients with Alzheimer\u2019s disease and other dementias. Focus Am Psychiatr Publ. 2017;15:110\u201328.","journal-title":"Focus Am Psychiatr Publ"},{"key":"2259_CR68","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1701131","volume":"377","author":"RP Giugliano","year":"2017","unstructured":"Giugliano RP, Mach F, Zavitz K, Kurtz C, Im K, Kanevsky E, et al. Cognitive function in a randomized trial of evolocumab. N Engl J Med. 2017;377:633\u201343.","journal-title":"N Engl J Med"},{"key":"2259_CR69","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1093\/eurheartj\/ehy182","volume":"39","author":"F Mach","year":"2018","unstructured":"Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, et al. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J. 2018;39:2526\u201339.","journal-title":"Eur Heart J"},{"key":"2259_CR70","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-024-01257-9","volume":"27","author":"A Bao","year":"2024","unstructured":"Bao A, Karalis DG. Statin therapy for primary and secondary prevention in older adults. Curr Atheroscler Rep. 2024;27:11.","journal-title":"Curr Atheroscler Rep"},{"key":"2259_CR71","first-page":"e1082","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019;139:e1082\u2013143.","journal-title":"Circulation"},{"key":"2259_CR72","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/ana.27285","volume":"98","author":"M Mila-Aloma","year":"2025","unstructured":"Mila-Aloma M, Tosun D, Schindler SE, Hausle I, Petersen KK, Li Y, et al. Timing of changes in Alzheimer\u2019s disease plasma biomarkers as assessed by amyloid and tau PET clocks. Ann Neurol. 2025;98:508\u201323.","journal-title":"Ann Neurol"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02259-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02259-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02259-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:02:27Z","timestamp":1783771347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02259-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":72,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2259"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02259-y","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}